National HIV Surveillance System (NHSS)

 

Executive Summary The National HIV Surveillance System (NHSS) is the mechanism through which the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Division of HIV/AIDS Prevention (DHAP), HIV Incidence and Case Surveillance Branch (HICSB) monitors trends in HIV infection diagnoses in the United States. Data collected on reported HIV cases are also used to estimate the prevalence and incidence of HIV infections, progression of disease after diagnosis, and receipt of care (based on laboratory tests after diagnosis). NHSS data guide public health action at federal, state, and local levels and help public health officials develop, implement, and evaluate HIV prevention programs (including efforts to prevent disease progression after diagnosis). Information on HIV infection and disease progression can be used to determine where HIV prevention services are most needed and ensure that persons living with HIV infection receive appropriate care. CDC-funded health departments report HIV case surveillance data to NHSS. The CDC National HIV Prevention Program Monitoring and Evaluation (NHM&E) system provides data about CDC-funded HIV testing and other prevention activities conducted by CDC-funded health departments and community-based organizations. HIV testing is one of the DHAP core HIV prevention strategies. NHM&E testing data are used at federal, state and local levels to inform HIV prevention policy, program decision-making, and program monitoring and evaluation activities. Tracking persons newly diagnosed with HIV infection and their timely access to HIV medical care is important for CDC-funded HIV prevention programs. This supplement is an expansion of activities under FOA CDC-RFA-PS13-1302. The purpose of the project is to improve the quality and completeness of CDC-funded HIV testing data through the sharing of data between the HIV surveillance program and the HIV prevention program at each health department. Health departments will implement strategies for sharing HIV testing and HIV case surveillance data between these two programs to improve the accuracy of data on new and pre-existing HIV diagnoses and linkage to HIV medical care among persons newly diagnosed with HIV infection.

Deleted 11/04/2015 (Archived.) CDC-RFA-PS13-13020401SUPP16 Agency: Department of Health and Human Services
Office: CENTERS FOR DISEASE CONTROL Cooperative Agreement 20 Eligible Applicants: Competition is limited to jurisdictions currently funded under FOA CDC-RFA-PS13-1302 for HIV case surveillance (Component A) who met the following criteria for the collection and reporting of CD4 and viral load test results as of December 2014: The jurisdiction’s laws/regulations required the reporting of all CD4 and viral load results to the state/city health department. Laboratories that perform HIV-related testing for the jurisdictions had reported a minimum of 95% of HIV-related test results to the state/city health department. The jurisdiction had reported (to CDC) at least 95% of all CD4 and viral load test results received from January 2012 through September 2014. The following jurisdictions may apply: Alabama, Alaska, Arkansas, California, Chicago; the District of Columbia; Hawaii; Houston; Illinois; Indiana; Iowa; Los Angeles; Louisiana; Maine; Maryland; Michigan; Missouri; Nebraska; New Hampshire; New York City; New York State; North Dakota; Oregon; San Francisco; South Carolina; South Dakota; Tennessee; Texas; Utah; Virginia; Washington; West Virginia; Wisconsin. Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. 10/05/2015 This program does not have cost sharing or matching requirements. Levator Brown
lxb4@cdc.gov
lxb4@cdc.gov $1,200,000.00 Awards range from $20,000.00 to $120,000.00